Article By:
Moon Kil Woong
Tuesday, July 27, 2021 9:01 AM EDT
PLX was up on FDA notice last year on a CRL postponement that its PDUFA review of PRX-102. In the meantime, phase III trials continue to provide more positive results. It is a stock worth watching.
There Is Beta In Protalix Stock Due To PRX-102
I'm liking what I see about $PLX!
There Is Beta In Protalix Stock Due To PRX-102
Are there any other recombinant therapeutics that are in the pipeline for $PLX
There Is Beta In Protalix Stock Due To PRX-102
I'll be taking a closer look at $PLX, thanks.
Protalix BioTherapeutics Pipeline Progress
Just read another good article about $PLX out today:
There Is Beta In Protalix Stock Due To PRX-102
talkmarkets.com/.../there-is-beta-in-protalix-stock-due-to-prx-102
There Is Beta In Protalix Stock Due To PRX-102
$PLX sounds like a promising company
Protalix BioTherapeutics Pipeline Progress
Thanks for your thoughts. I'm interested in this company but would like to see more info about $PLX before investing. However, good coverage seems to be sparse.
Protalix BioTherapeutics Pipeline Progress
#Protalix clearly has a lot of potential but there's a limited number of people who will need this drug. So the real question is how much of a dent will they put into #Sanofi's market share. $PLX $SNY
Protalix BioTherapeutics Pipeline Progress
My pleasure. What's more important than how prevalent the disease is, is how much money #Protalix can make on its new drug. It's competitor, #Sanofi ($SNY) makes $1 billion in revenue annually on their drug. Protalix's sounds like a more promising alternative. I'd definitely rate $PLX a buy.
Protalix BioTherapeutics Pipeline Progress
Good article, nicely done. I will be checking out $PLX.
Protalix BioTherapeutics Pipeline Progress
Thank you for this article. Are there any other recombinant therapeutics that are in the pipeline for them? $PLX